(Reuters) - Amag Pharmaceuticals Inc said on Thursday chief executive officer would step down and it plans to divest two of its women's health drugs, bowing to pressure from investor Caligan Partners ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Oct 8 (Reuters) - Amag Pharmaceuticals Inc, whose shares have tumbled more than 45% in the past year, on Tuesday agreed to add two directors proposed by Caligan Partners after the hedge fund pressured ...

WALTHAM, Mass., May 21, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced it has completed the sale of its rights to Intrarosa® (prasterone) to Millicent Pharma ...

WALTHAM, Mass., April 28, 2020 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that its Board of Directors has appointed Scott Myers as AMAG’s President and Chief ...

When looking for consumer marketing lessons that can translate to pharma, Amag Pharmaceutical needed to look no further than its own operations. Amag recently laid out its effort to apply lessons from ...

AMAG Pharmaceuticals has big ambitions for its women’s health business, so it’s snapped up the rights to a new med, Intrarosa, to beef up that portfolio. And it’s bringing on 150 new reps to detail ...

(Reuters) - Amag Pharmaceuticals Inc's treatment to boost sexual desire in premenopausal women will be offered at $899 and is the only injectable drug on the market for hypoactive sexual desire ...

(Reuters) - Amag Pharmaceuticals Inc , whose shares have tumbled more than 45% in the past year, on Tuesday agreed to add two directors proposed by Caligan Partners after the hedge fund pressured the ...